Abstracts of the 9th Congress of the European Society of Contraception

 

"Improving life quality through contraception and reproductive health care" 

3-6 MAY 2006 ISTANBUL/ TURKEY

1  Non-contraceptive benefits of contraceptives 9  Emergency contraception
2  Hormonal contraception 10  Complications of oral contraceptives
3  Counselling for contraception 11  IUDs 
4  Adolescent contraception 12  Contraception and infections
5  Cancer and contraception 13  Sexual and Reproductive Health Services
6  New contraceptive methods 14  Sexual Health Education for young people
7  Abortion 15  Quality in reproductive health services
8  Male contraception 16  Other topics 

P009  Women are less likely to experience irregular bleeding when switching to NuvaRing compared with combined oral contraceptives-data from a pooled analysis  Abstract
I Milsom1, E Ng2, J in 't Hout3 1Sahlgrenska Academy at Göteborg University, Department of Obstetrics and Gynaecology, Göteborg, Sweden, 2Organon International, Medical Services, Roseland, NJ, United States, 3NV Organon, Biometrics Department, Oss, Netherlands
P010  Effectiveness and reasons for discontinuation in Implanon users in Turkish women  Abstract
E. Z. Tuzcular Vural, I. Gönenç, N. Aka, G. Köse Haydarpasa Numune Education and Research Hospital, Family Planning Unit, Istanbul, Turkey 
P011 Contraceptive efficacy with NuvaRing vs two combined oral contraceptives-data from a pooled analysis  Abstract
H-J Ahrendt1, M Nap2, MZ Marintcheva-Petrova3 1Private Practice, Magdeburg, Germany, 2NV Organon, Medical Services, Oss, Netherlands, 3NV Organon, Biometrics Department, Oss, Netherlands 
P012  Efficacy of the oral contraceptive Belara® in acne resolution rates: a randomised, double-blind, placebo-controlled phase III-trial Abstract
A Mendelin Grünenthal GmbH, Aachen, Germany 
P013 Factors effecting continuation rates in users of monthly contaceptive injections in Turkish women  Abstract
I. Gönenç, EZ. Tuzcular Vural, G. Köse, N. Aka Haydarpaca Numune Education and Research Hospital, Family Planning Unit, Istanbul, Turkey 
P014 Adverse effects, effectiveness, and discontinuation of the subdermal implant, implanon  Abstract
H.G Sahin, A Kolusari, E Erdemoglu, S Zeteroglu, H.A Sahin, B Yildizbas, M Kamac Yuzuncu Yil University Med. Faculty Obs & Gyn Department, Van, Turkey 
P015 Clinical and microbiological aspects of the lower genital tract infections under hormonal contraception  Abstract
I.E. Blidaru1, M. Scripcaru2, A. Nistor2, I. Catighera3, R. Plesca3, M. Roman3, V. Ciuchi1 14-th Department of Obstetrics & Gynecology, "Gr. T. Popa" University of Medicine and Pharmacy, Iasi, Romania, 2"M. Ciuca" Institute of Public Health, Iasi, Romania, 3Family Planning Unit, "Cuza-Voda" Maternity Hospital, Iasi, Romania
P016 Clinical experience with NuvaRing® in Spain shows that the monthly contraceptive ring is associated with a low incidence of hormone-related adverse effects  Abstract
I Lete Lasa Santiago Apóstol Hospital, Gynecology Department, Vitoria, Spain
P017 The effect of the use of the combine oral contraceptive, intrauterine contraceptive device and subdermal contraceptive implant on basal ovarian volume Abstract
L Karci, B Cetinkaya, A Baloglu, I Bezircioglu Aegean University, Obstetric and Gynecology Department, Izmir, Turkey   
P018 Experience of using the innovative contraceptive NuvaRing in Ukraine Abstract
I.V. Vovk, L. Novik, G. Chubei Institute of Pediatrics, Obstetrics and Gynecology, Kiev, Ukraine
P019 Modulation of Ovarian Function by a Combined Oral Contraceptive Containing 30 µg Ehinyl Estradiol and 2 mg Chlormadinone Acetate  Abstract
J Spona, W Feichtinger, N Binder, K Höschen Czerningasse 10, 1020 Vienna, Austria, Wunschbabyzentrum, 1020, Austria, Gruenenthal GmbH, 52078 Aachen, Germany
P020 Clinical experience, acceptability and effects of implanon on biochemical, hematological, hemostatical and hormonal parameters: during the first 6 months of insertion Abstract
B Yildizbas, H.G Sahin, A Kolusari, E Erdemoglu, S Zeteroglu, M Kamaci Yuzuncu Yil University, Med Faculty, Obs & Gyn. Department, Van, Turkey

P021 High acceptability of NuvaRing® in Lithuania-a clinical experience program Abstract
V Vasjanova1, R Jakubcionyte2, R Cepuliene3 1Vilnius Seskines Women Consultation Centre, Vilnius, Lithuania, 2Kaunas Medical University Clinics, Obstetrics and Gynaecology Clinics, Kaunas, Lithuania, 3Organon Lithuania, Medical Department, Vilnius, Lithuania 
P022 The psycho-emotional state of fertile women who use the contraceptive NUVARING  Abstract
V.V. Podolskyi, V. Dronova, M. Gulchiy, R. Teslyuk Institute of Pediatrics, Obstetrics and Gynecology, Kiev, Ukraine
P023 Experience with the use of implanon within a community contraceptive service clinic Abstract
V. McNamara, E.J. Oloto Contraceptive Services, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
P024 Efficacy and tolerability of transdermal hormonal contraception over 6 months  Abstract
A J Jakimiuk1, P Madalenet2, T Chernev3, K Cha'Ban4, P Bergmans5, M Preik6, E Lee7 1Polish Academy of Sciences, Medical Research Centre, Warsaw, Poland, 2Hopital Bichat Claude Bernard, Service de gynecologie-obstetrique, Paris, France, 3University Maternity Hospital 'Maichin dom', Clinic for fetal medicine, Sofia, Bulgaria, 4St Vincentiusziekenhuis, Antwerp, Belgium, 5Janssen-Cilag, Tilburg, Netherlands, 6Janssen-Cilag, Medical & Scientific Affairs, Neuss, Germany, 7Janssen-Cilag, EMES Nedical Affairs, Beerse, Belgium 
P025 A cross-sectional study of the forearm bone density of long-term users of the levonorgestrel-releasing intrauterine system, Mirena®  Abstract
C.R.T. Juliato, L. Bahamondes, M.M. Hidalgo, C. Hidalgo-Regina, X. Espejo-Arce, C.A. Petta Human Reproduction Unit, Department of Obstetrics and Gynaecology, School of Medicine, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil 
P026 Low-dose estrogen oral contraceptives and fat patterning in young women Abstract
M Taebi1, M Noroozi2, Z Paknahad3 1Kashan medical science university,Department of nursing& midwifery, Kashan, Iran, 2Isfahan medical science university,Department of nursing& midwifery, Isfahan, Iran, 3Isfahan medical science university, Department of hygiene, Isfahan, Iran
P027 Choosing the right contraceptive method - development of a clinical pathway Abstract
A Mendelin Grünenthal GmbH, Aachen, Germany
P028 Transdermal contraception is associated with high levels of patient satisfaction and compliance  Abstract
A J Jakimiuk1, P Madalenet2, T Chernev3, K Cha'Ban4, P Bergmans5, M Preik6, E Lee7 1University School of Medicine, Department of Gynaecology, Lublin, Poland, 2Hopital Bichat Claude Bernard, Service de Gynecologie-Obstetrique, Paris, France, 3University Maternity Hospital 'Maichin dom', Clinic for Fetal Medicine, Sofia, Bulgaria, 4St Vincentiusziekenhuis, Antwerp, Belgium, 5Janssen-Cilag, Tilburg, Netherlands, 6Janssen-Cilag, Medical & Scientifc Affairs, Neuss, Germany, 7Janssen-Cilag, EMEA Medical Affairs, Beerse, Belgium 
P029 Switching hormonal contraceptives to a CMA-containing oral contraceptive - Contraceptive switch study   Abstract
A Mendelin Grünenthal GmbH, Aachen, Germany
P030 Oral contraceptive containing drospirenone and 24-hour ambulatory blood pressure. Preliminary data from a prospective study   Abstract
A. Tirelli, A. Volpe, C. Alessandrini, S. Ferrari, A. Cagnacci University of Modena, Dept Obstetrics Gynecology and Pediatrics, Modena, Italy

P031 The hormonal contraception methods using features of the women who applied the family planning centre in Eskisehir (Turkey)  Abstract
H. Karabagli, D. Arslantas, S. Metintas, A. Ekenel The Office of Mother/Child Health and Family Planning Services, Eskisehir, Turkey, Eskisehir-Osmangazi University, Medical Faculty, Department of Public Health, Eskisehir, Turkey, Eskisehir-Osmangazi University, Medical Faculty, Department of Public Health, Eskisehir, Turkey, The Office of Mother/Child Health and Family Planning Services, Eskisehir, Turkey 
P032 Evaluation of the pregnancy rate, hyperlipidemia, hyperglycemia and abnormal bleeding in progestron only pill (POP) users during breastfeeding  Abstract
Maryam Kashanian, Mohsen Fekrat Iran University of Medical Sciences, Tehran, Iran 
P033 Morphological study of mice endometrium in preimplantation period  Abstract
Y Dezhkam, R Sadrkhanlou Urmia islamic azad university/embryology, urmia/west azarbijan, Iran 
P034 The effect of oral contraceptives containing gestodene on Cox-2 expression in the endometrium  Abstract
H. Maia Jr.1, J Casoy1, T. Correa2, L. Freitas3, C. Athayde1, K. Pimentel2, E.M. Coutinho1 1CEPARH, Salvador, Bahia, Brazil, 2Escola Bahiana de Medicina, Salvador, Bahia, Brazil, 3Fiocruz, Salvador, Bahia, Brazil 
P035 Attitudes and experiences of Mesigyna users at family planning services of Umraniye,Istanbul - A qualitative research  Abstract
A. Karahan1, S. Kalaca1, A. Karahan2, S. Hidiroglu1, F. Demir1 1Marmara University School of Medicine, Public Health, Istanbul, Turkey, 2Lutfiye Nuri Burat Hospital, Internal Medicine, Istanbul, Turkey
P036 Yasmin use in clinical practice and family planning center  Abstract
Gjergj Theodhosi, Merita Alushani, Elin Kurti, Fatmir Kopani Obstetric Gynecologic Universitary Hospital Mbreteresha Geraldine, Tirana, Albania
P037 Characteristics of the contraception with methods of only gestagen  Abstract
N. Parera, E. de la Viuda, R. Lertxundi Board of Directors, Madrid, Spain 
P038 Mercilon ® - oral contraceptive in adolescent fertility control  Abstract
M Pavlov-Mirkovic, M Bogavac Clinical Centre Novi Sad, Department of Obstetrics and Gynecology, Novi Sad, Serbia & Montenegro 
P039 Comparison of two contraceptive implants: Levonorgestrel versus Etonogestrel  Abstract
H Aktun, B Polat, R Neslihanoglu, I Tarhan, L Mollamahmutolu Zekai Tahir Burak Maternity Hospital, Ankara, Turkey 
P040 Contraceptive with antimineralcorticoid and antiandrogenenic activity  Abstract
V.N. Prilepskaya, L.I. Ostreikova Research Center of Obstet., Gynec. and Perinat., Moscow, Russia

P041 Contraceptive efficacy and safety of low dose oral monophasic contraceptives  Abstract
D Tutunaru1, I Badea2, F D Lebit1, M C Dumitrascu2 1Elias Emergency Hospital, Bucharest, Romania, 2Universitary Emergency Hospital, Bucharest, Romania 
P042 Updating of the election criteria of the AHC  Abstract
I. Ramirez, E. López Arregui, J.L. Doval Conde Board of Directors of the Spanish Society of Contraception, Madrid, Spain 
P043 The administration criteria and the way of administration did not modify the effectiveness and the security of the AHC  Abstract
M.A. Gomez, E. Barranco, E. Pérez Campos Board of Directors of Spanish Society of Contraception, Madrid, Spain 
P044 Continuity of Implanon usage after three years of use  Abstract
K Ertopcu, MM Inal, N Kokturk, I Ozelmas, S Tinar Aegean Obst&Gyn Teaching and Research Hospital Family Planning Department, Izmir, Turkey 
P045 Efficacy and tolerance of emergency contraception with Escapel   Abstract
V.N. Prilepskaya, T.N. Bebneva, P.R. Abakarova Research Center of Obstet., Gynec. and Perinat., Moscow, Russia
P046 Menstrual pattern and lipid profiles during use of Medroxyprogesterone acetate and estradiol cypionate (Cyclofem) and Depo medroxy progesterone acetate (DMPA) as contraceptive injections, lesson learned from Iran   Abstract
F. Ramezani Tehrani, H. Malek Afzali, M. Simbar National Research Center for Reproductive Health, Tehran, Iran
P047 The evaluation of subdermal contraceptive implant cases in our clinic  Abstract
B Cetinkaya, I Bezircioglu, S Yilmaz, L Karci, A Baloglu Aegean University, Obstetric and Gynecology Department, Izmir, Turkey 
P048 Cycle control with the monthly contraceptive ring - ETN® study  Abstract
I. Lete Santiago Apóstol Hospital, Vitoria, Spain 
P049 Menstrual pattern with the monthly contraceptive ring - ETN® study  Abstract
I. Lete Santiago Apostol Hospital, Vitoria, Spain
P050 Acceptance of the administration route in users of the monthly contraceptive ring - ETN® study  Abstract
I. Lete Santiago Apostol Hospital, Vitoria, Spain

home